CD200 and cancer: Using the deconvolved TCGA-BRCA dataset, we found that patients with high CD200 levels in cancer cells also showed high levels of CD200R1 in NK cells, CD14+ myeloid cells, and Treg (Figure 7G), consistent with our observations in mouse models.